Hematologic Malignancies Program

Hematologic Malignancies Program - ACC - Penn Medicine

The Hematologic Malignancies Program aims to translate basic scientific discoveries into therapeutics for patients with myeloid and lymphoid neoplasms.

Hematologic Malignancies Program - Cancer Center

Supported by expert physician-scientists, the Hematologic Malignancies Program conducts innovative research to advance the understanding and treatment of ...

Hematological Malignancies Program | St. Jude Research

The Hematological Malignancies Program's overall goal is to advance cure rates for children with leukemia while minimizing acute and late sequelae of ...

Blood Cancer (Hematological Malignancies) Program - Penn Medicine

Penn Medicine blood cancer specialists provide diagnostic testing and advanced treatments for hematological malignancies, which start in the bone marrow.

Hematologic Malignancies Program - City of Hope

City of Hope's comprehensive cancer center Hematologic Malignancies Program aims to improve outcomes for patients with leukemia, lymphoma, Hodgkin's disease ...

Center for Hematologic Malignancies

The Center for Hematologic Malignancies (CHM) serves patients with blood cancers, including leukemia, lymphoma, and myeloma.

Hematopoietic Development and Malignancy Program (HDMP)

Siteman Cancer Center is a leader in cancer treatment, research & education. Learn more about Research Programs & Hematopoietic Development and Malignancy ...

Annual Congress- Hematologic Malignancies - NCCN

The NCCN 2025 Annual Congress: Hematologic Malignancies™ will take place Friday, October 10 - Saturday, October 11, 2025 at the Hilton San Diego Bayfront, San ...

Hematopoiesis & Hematologic Malignancies (HHM) Research ...

The goal of the Hematopoiesis and Hematologic Malignancies (HHM) research program at IU Simon Comprehensive Cancer Center is to enhance treatment of ...

Hematologic Malignancies and Bone Marrow Transplant

Through cross-specialty collaborations, Program scientists have built upon advances in genetic (mutations to DNA) epigenetic (chemical alterations to the ...

Hematologic Malignancies Research Institute - City of Hope

As a pioneer in advancing care for all hematologic cancers and related blood disorders, City of Hope's Hematologic Malignancies Research Institute leads the ...

Northside launches new program for hematologic malignancies

Northside launches new program for hematologic malignancies ... Northside Hospital Cancer Institute has launched a new Hematologic (Heme) ...

Hematologic Malignancies - ACCC Cancer

Acute Myeloid Leukemia (AML) is the most diagnosed blood cancer in adults. ACCC has initiated the education program to explore and address current barriers in ...

Hereditary Hematologic Malignancy Genetics Program

This program helps to identify and provide comprehensive, coordinated medical care for families that have a hereditary risk for blood cancers.

Hematological Malignancy Program | Lurie Children's

A comprehensive program dedicated to providing world-class care to children, adolescents, and young adults with blood and lymph node cancers.

Hematological Malignancy Program - Cincinnati Children's Hospital

The Hematological Malignancy Program at Cincinnati Children's is focused on these areas of research.

Older Adult Hematologic Malignancy (OHM) Program

New Patient Appointments ... The Older Adult Hematologic Malignancy (OHM) Program is a specialized Dana-Farber Brigham Cancer Center research and clinical service ...

Research Programs | Sandra and Edward Meyer Cancer Center

Experimental Therapeutics Program advances cancer therapeutics through innovative clinical research across organ sites. The program emphasizes cancers that are ...

Hematologic Malignancies and Cellular Therapy

The mission of the division of Hematologic Malignancies and Cellular Therapy is to promote health and improve lives by preventing, diagnosing, and treating ...

Hematologic Malignancies Program - Cleveland - University Hospitals

Hematologic Malignancies Program, Hospital, University Hospitals Seidman Cancer Center, Key Contacts, Brenda Cooper, MD, Disease Team Leader, Medical Oncology.